#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thyroid cancer metastatic B-cell small lymphocytic lymphoma recurrent Cardiac arrest Netherton's syndrome Neonatal asphyxia Metastases to central nervous system Sexually transmitted disease Salivary gland cancer Myeloproliferative neoplasm Adrenogenital syndrome Liposarcoma recurrent Microvillous inclusion disease Fibrosarcoma B-cell lymphoma refractory Methylmalonic acidaemia More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Trials in Disease Carcinoid syndrome Lennox-Gastaut syndrome – Treatment IgA nephropathy – Life with Disease Mucopolysaccharidosis Cytokine release syndrome – Diagnostics Adrenogenital syndrome – Trials in Disease Pleural mesothelioma malignant – Basic Information Choroid melanoma – Diagnostics Hereditary motor and sensory neuropathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluvastatin GLYCYL-TYROSINE 18F-Fludarabine CC-97540 Pimecrolimus N-Acetylhistidine Farletuzumab Ecteribulin Gilteritinib Magnesium Citrate TEV-53408 Venetoclax Atorvastatin Calcium Cefoxitin Choriogonadotropin Alfa Phosphocreatine Sodium Annamycin OLVEREMBATINIB Reboxetine LUMC-BOB1-B7-TCR.1 Fosfomycin Trometamol More therapies…

    Learn about Your Condition

    Delirium Hypophosphatasia Obstructive pancreatitis Pancreatic carcinoma Blood disorder Dent's disease Schizophreniform disorder Univentricular heart Adrenocortical carcinoma Double hit lymphoma Myocarditis Ovarian cancer stage III Pemphigoid Adenocarcinoma pancreas Spina bifida More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on How Tacrolimus Monohydrate and Mycophenolate Mofetil Affect Gut Bacteria in Patients with Chronic Kidney Disease After Transplant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus Monohydrate
    • Mycophenolate Mofetil
    Belgium

  • Study on Early Immunotherapy with Human Normal Immunoglobulin, Cyclophosphamide, and Methylprednisolone for Patients with Anti-Hu Paraneoplastic Sensory Neuropathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paraneoplastic neurological syndrome
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Mesna
    • Human Normal Immunoglobulin (Iv)
    France

  • Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Abiraterone Acetate
    • Darolutamide
    • Enzalutamide
    Austria Belgium Finland France Germany Hungary +5

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    • Prednisone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    • Gd2Il18Cart
    • Anakinra
    Germany

  • Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Saline
    • Vancomycin
    Sweden
Previous Page
1 … 450 451 452 453 454 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!